drugset / Trial / NCT00956020

Evaluation of the Mechanism of Action of Platelet Rich Fibrin Matrix (PRFM) in Producing Skin Volume Augmentation

NCT00956020 ↗

Phase 1/2 Completed 4 enrolled The New York Eye & Ear Infirmary
NaSingle-groupOpen-labelTreatment

Summary

Autologous platelet rich fibrin matrix will release growth factors which could increase the production of dermal proteins or affect the vascularity and status of neighboring tissues. This study is designed to evaluate the histologic and biochemical effect of injection of platelet rich fibrin matrix into the skin.

Timeline

Start
2009-10
Primary completion
2011-02
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet rich fibrin matrix Unknown — Other

Indications

No indication recorded.